Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript

Hims & Hers Health, Inc. ( HIMS ) Q2 2026 Earnings Call August 10, 2026 5:00 PM EDT Company Participants William Newby - Senior Director of Investor Relations Andrew Dudum - Co-Founder, Chairman & CEO Mohamed ElShenawy - Chief Technology Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Maria Ripps - Canaccord Genuity Corp., Research Division Ryan MacDonald - Needham & Company, LLC, Research Division Mark Stephen Mahaney - Evercore ISI Institutional Equities, Research Division Craig Hettenbach - Morgan Stanley, Research Division Eric Percher - Nephron Research LLC Glen Santangelo - Barclays Bank PLC, Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to the Hims & Hers Health Second Quarter 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Bill Newby, Director of Investor Relations. Bill, please go ahead. William Newby Senior Director of Investor Relations Good afternoon, everyone, and welcome to the Hims & Hers Health Second Quarter 2026 Earnings Call. On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer; Yemi Okupe, our Chief Financial Officer; and Mo ElShenawy, our Chief Technology Officer. Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on, among other things, our current market, competitors and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions or otherwise. The risks, uncertainties and other factors that could cause actual results to differ from our forward-looking statements are described in our earnings release and SEC filings. Please see our recent